ID

23694

Beschrijving

Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00668642

Link

https://clinicaltrials.gov/show/NCT00668642

Trefwoorden

  1. 10-07-17 10-07-17 -
Geüploaded op

10 juli 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Prostate Cancer NCT00668642

Eligibility Prostate Cancer NCT00668642

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically proven prostate cancer
Beschrijving

ID.1

Datatype

boolean

Alias
UMLS CUI [1]
C0007112
patients are hormone-naive
Beschrijving

ID.2

Datatype

boolean

Alias
UMLS CUI [1]
C0019932
patients either to begin androgen ablation therapy with lhrh agonist or already receiving therapy with lhrh agonist
Beschrijving

ID.3

Datatype

boolean

Alias
UMLS CUI [1]
C1298673
advanced prostate cancer with either positive pelvic nodes or bone/visceral metastasis
Beschrijving

ID.4

Datatype

boolean

Alias
UMLS CUI [1,1]
C0376358
UMLS CUI [1,2]
C0027627
must have an intact prostate (no previous surgery or xrt)
Beschrijving

ID.5

Datatype

boolean

Alias
UMLS CUI [1,1]
C0033572
UMLS CUI [1,2]
C0436209
UMLS CUI [1,3]
C0038895
ecog performance status 0-2
Beschrijving

ID.6

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
recovery from any major infection or surgical procedure
Beschrijving

ID.7

Datatype

boolean

Alias
UMLS CUI [1,1]
C0543467
UMLS CUI [1,2]
C2004454
UMLS CUI [1,3]
C3714514
signed informed consent
Beschrijving

ID.8

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
known intolerance or allergy to dutasteride
Beschrijving

ID.9

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0754659
concomitant chemotherapy, biologic therapy, or xrt to prostate
Beschrijving

ID.10

Datatype

boolean

bilateral orchiectomy
Beschrijving

ID.11

Datatype

boolean

Alias
UMLS CUI [1]
C0007347
prior malignancy within 5 years of registration
Beschrijving

ID.12

Datatype

boolean

Alias
UMLS CUI [1]
C0455471

Similar models

Eligibility Prostate Cancer NCT00668642

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
histologically proven prostate cancer
boolean
C0007112 (UMLS CUI [1])
ID.2
Item
patients are hormone-naive
boolean
C0019932 (UMLS CUI [1])
ID.3
Item
patients either to begin androgen ablation therapy with lhrh agonist or already receiving therapy with lhrh agonist
boolean
C1298673 (UMLS CUI [1])
ID.4
Item
advanced prostate cancer with either positive pelvic nodes or bone/visceral metastasis
boolean
C0376358 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
ID.5
Item
must have an intact prostate (no previous surgery or xrt)
boolean
C0033572 (UMLS CUI [1,1])
C0436209 (UMLS CUI [1,2])
C0038895 (UMLS CUI [1,3])
ID.6
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
ID.7
Item
recovery from any major infection or surgical procedure
boolean
C0543467 (UMLS CUI [1,1])
C2004454 (UMLS CUI [1,2])
C3714514 (UMLS CUI [1,3])
ID.8
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.9
Item
known intolerance or allergy to dutasteride
boolean
C0020517 (UMLS CUI [1,1])
C0754659 (UMLS CUI [1,2])
ID.10
Item
concomitant chemotherapy, biologic therapy, or xrt to prostate
boolean
ID.11
Item
bilateral orchiectomy
boolean
C0007347 (UMLS CUI [1])
ID.12
Item
prior malignancy within 5 years of registration
boolean
C0455471 (UMLS CUI [1])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial